News & Events Custom Posts View All News Events Natural Alternatives International, Inc. Announces 2025 Q1 Results CarnoSyn® Brands Announces New U.S. Distribution Agreement With B&D Nutritional Ingredients Natural Alternatives International, Inc. Announces Fiscal 2024 Q4 and YTD Results CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism CarnoSyn® Brands Unveils TriBsyn™- “The World’s First Paresthesia-Free Beta-Alanine Powder” Natural Alternatives International, Inc. Announces Fiscal 2024 Q3 and YTD Results Natural Alternatives Healthy After Supply Chain Disruption Natural Alternatives International Scheduled to Reopen U.S. Manufacturing Facility in California to Support Increased Production Needs CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-Alanine Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Results Natural Alternatives International, Inc. Announces 2024 Q1 Results Natural Alternatives International, Inc. Announces 2023 Q4 and YTD Results Natural Alternatives International, Inc. Announces Temporary Plant Closure and Employee Furloughs Natural Alternatives International Appoints New VP of Global Sales SR CarnoSyn® Sustained Release Beta-Alanine Selected as Finalist for Ingredient of the Year in Healthy Aging and Cognitive Function by NutraIngredients-USA Awards 2023 Natural Alternatives International Strengthens Capabilities by Adding New U.S. Manufacturing Facility in California Researchers Behind Recent Publication on SR CarnoSyn® Beta-Alanine Tablet’s Ability to Improve Cognitive Health Presenting at American College of Sports Medicine and Exercise Science (ACSM) 2023 Annual Meeting Natural Alternatives International, Inc. Announces 2023 Q3 and YTD Results Newly Published Study Shows SR CarnoSyn® Beta-Alanine Improves Cognitive Function In Older Adults Natural Alternatives International, Inc. Announces 2023 Q2 and YTD Results Natural Alternatives International, Inc. Announces 2023 Q1 Results NAI Appoints Aaron Starr Vice President for CarnoSyn® Brands Natural Alternatives Announces 2022 Q2 and YTD Results NAI Announces $3 Million Increase in Stock Repurchase Plan Beta-Alanine Set for Growth in Sports Nutrition Industry Natural Alternatives Announces 2022 Q1 Sales Results NAI to Announce First Quarter 2022 Financial Results NAI and CarnoSyn® Brands to Attend SupplySide West Show Natural Alternatives Announces 2021 Q4 and YTD Results NAI Acquires New Manufacturing and Warehouse Facility NAI Announces New and Expanded Wells Fargo Credit Facility NAI | First Company to Meet New SSCI Benchmarking Standards Natural Alternatives Announces 2021 Q3 and YTD Results How COVID-19 Shook the Sports Nutrition Market Stonegate Capital Partners Initiates Coverage on NAI NAI Announces Release of Investor Presentation The Role of Nutrients in Human Immune Response Metrics Natural Alternatives Announces 2021 Q2 and YTD Results NAI Has Repaid All Outstanding Credit Line Amounts Benefits Of Beta-Alanine Supplementation For Female Athletes NIE Awards Natural Alternatives Supplier of the Month Natural Alternatives Announces 2021 Q1 Financial Results FDA Debates NDI Enforcement Against Chinese-Produced Beta-Alanine NAI Announces Fiscal Year 2020 and Q4 Results Dr. Nancy Steely Appointed Vice President, R&D | NAI FDA, Supplement Manufacturer Debate NDI Import Alert Request Supplement Maker, FDA Met Several Times Over NDI Enforcement Supplement Industry, FDA Clash Over NDI Enforcement Supplement Industry May Have to Adopt Domestic Supply Chain NAI Honors First Responders with Video of San Diego from the Sky What Changes Will Last in the Supplement World Post-COVID? Beta-Alanine And The Importance Of Quality NAI Announces 2020 Q3 and YTD Financial Results Contract Manufacturing Comes of Age Immune-Health Roundtable: Ingredients Backed By Science Facility Telecommuting Announcement Natural Alternatives Announces Increase in Stock Plan Team CarnoSyn® Athletes Shine at 2020 NFL Scouting Combine Natural Alternatives Announces 2020 Q2 and YTD Results CarnoSyn® Brands Presents Wellness Solutions—IHS Conference NAI Announces Increase in its Stock Repurchase Plan Natural Alternatives Announces 2020 Q1 Results CarnoSyn® Brands Showcase Wellness Solutions—AMMG Conference CarnoSyn® Brands Showcase New Innovations at SupplySide West NAI Announces Fiscal Year 2019 and Q4 Results CarnoSyn® Wins NPA’s 2019 Ingredient and Science Award NAI Sues Vitalize Labs Over Alleged Trademark Infringement NAI Files Trademark Infringement Suit Against Vitalize Labs CarnoSyn® Wins 2019 Sports Nutrition Ingredient of the Year NAI | Enriching the World Through Nutrition Since 1980 NAI Announces Participation in the 2019 ifia® Japan! NAI Announces 2019 YTD and Q3 Financial Results Team CarnoSyn® Prevails in the 2019 NFL Draft Beta-Alanine for Food Application Receives Approval in Japan NAI & The Juice Plus+® Company Extend Manufacturing Contract Natural Alternatives Trumpets IP Protection Patent Victory NAI Prevails in Federal Circuit Appeal on CarnoSyn® Patents Team CarnoSyn® Fuels 2019 NFL Hopefuls with Sponsorships CarnoSyn® Receives New Dietary Ingredient Status From FDA Natural Alternatives Announces 2019 Q2 and YTD Results NAI to Participate in 2019 Integrative Healthcare Symposium Natural Alternatives Announces 2019 Q1 Results NAI Announces New Website Launch to Support Market Expansion Natural Alternatives Announces Fiscal 2018 and Q4 Results Visit NAI at SupplySide West Booth #4933 The New EU Meal Replacement Regulations Get the Facts About the FDA Nutrition Facts Label Transition NAI Exhibits at the DSA Conference in San Diego Natural Alternatives Announces Fiscal 2018 Q3 Results Natural Alternatives Announces Fiscal 2018 Q2 Results NAI Reports Allowance of New Beta-Alanine Patent Application Load More
